F-star Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. F-star Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 88% to $21,167,000. Profit margin reached -148%. Total operating expenses were $51,881,000.
Profit Margin
| 2016 | 0 | -17.36M | |
|---|---|---|---|
| 2017 | 0 | -27.67M | |
| 2018 | 0 | -22.85M | |
| 2019 | 28.32M | -23.01M | -81.26% |
| 2020 | 11.25M | -25.61M | -227.6% |
| 2021 | 21.16M | -31.28M | -147.79% |
FSTX Income Statement (2016 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 21.16M | 11.25M | 28.32M | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 21.16M | 11.25M | 28.32M | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 28.75M | 14.12M | 31.38M | 19.75M | 13.07M | 14.01M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 51.88M | 33.64M | 46.66M | 28.47M | 21.25M | 19.75M |
Operating income | -30.71M | -22.38M | -22.49M | -28.47M | -21.25M | -19.40M |
Other income (expenses), net | -941K | -3.23M | -1.25M | 5.61M | -6.42M | 2.03M |
Income before tax | -31.65M | -25.62M | -23.75M | -22.85M | -27.67M | -17.36M |
Income tax expense | -372K | -1K | -737K | 0 | 0 | 0 |
Net income | -31.28M | -25.61M | -23.01M | -22.85M | -27.67M | -17.36M |
Earnings per share | ||||||
Basic EPS | -1.88 | -9.69 | -2.54 | -0.00 | -0.00 | -0.00 |
Diluted EPS | -1.88 | -9.69 | -2.54 | -0.00 | -0.00 | -0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source |